Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07174388 · ClinicalTrials.gov registry record
A Study in Non-Small Cell Lung Cancer
A clinical trial of Non-Small Cell Lung Cancer, sponsored by N-Power Medicine.
- Recruiting
- Registry status
- 550
- Enrollment target
- 3
- Study locations
NCT07174388: Recruiting study of Non-Small Cell Lung Cancer, sponsored by N-Power Medicine.
NCT07174388 is a study of Non-Small Cell Lung Cancer that is actively recruiting participants, run by N-Power Medicine. The registered enrollment target is 550 participants, below the 651-participant average among 454 other Non-Small Cell Lung Cancer trials with a reported enrollment target (16% lower). The trial reports 3 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07174388, a study of Non-Small Cell Lung Cancer, is actively recruiting participants, sponsored by N-Power Medicine.
- RECRUITING
- Registry status
- 550 participants
- Enrollment target
- 3
- Study locations
Study Summary
A study to create control arms using current and future information in patients with lung cancer that has spread who have already received chemotherapy.
Conditions Studied
Study Locations (3)
Delaware
- Bayhealth Medical Center, Kent Campus - Dover
- Bayhealth Medical Center- Sussex Campus - Milford
California
- Pacific Cancer Care - Monterey
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 550 participants |
| Start Date | 2026-01-07 |
| Est. Completion | 2029-04 |
What NCT07174388 shows while recruiting
NCT07174388 is an observational study that tracks outcomes without assigning an intervention. The registered 550 participants enrollment target is mid-sized for trials with a published cap, below the 651-participant average among 454 other Non-Small Cell Lung Cancer trials with a reported enrollment target (16% lower).
The record links to 1 condition, with Non-Small Cell Lung Cancer appearing as the primary indexed condition, and to 0 interventions.
NCT07174388 reports a single indexed study location in Delaware, California.
Frequently Asked Questions
What is clinical trial NCT07174388 about?
NCT07174388 is a clinical study titled "A Study in Non-Small Cell Lung Cancer". A study to create control arms using current and future information in patients with lung cancer that has spread who have already received chemotherapy.
What is the current status of trial NCT07174388?
This trial is currently recruiting. The enrollment target is 550 participants. The study started on 2026-01-07. Estimated completion is 2029-04.
What conditions does trial NCT07174388 study?
This clinical trial studies the following conditions: Non-Small Cell Lung Cancer.
Who is sponsoring clinical trial NCT07174388?
This trial is sponsored by N-Power Medicine, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07174388 being conducted?
This trial has 3 study locations across California, Delaware. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Non-Small Cell Lung Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07174388's enrollment target sits among peer trials
550 67th of 454 higher than 388 of 454 other Non-Small Cell Lung Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Non-Small Cell Lung Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study to Evaluate Safety, Efficacy, and Pharmacokinetics in Participants With Advanced Solid Tumors
RECRUITING · Phase 1
-
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
RECRUITING · Phase 3
-
A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers
RECRUITING · Phase 1
-
Neoadjuvant Dupilumab and Cemiplimab in Patients With Early-stage Resectable NSCLC
RECRUITING · Phase 1
-
A Study Investigating BG-60366 in Adults With Epidermal Growth Factor Receptor (EGFR)-Mutant Non-Small Cell Lung Cancer
RECRUITING · Phase 1
-
Clinical Trial Evaluating the Safety, Tolerability and Preliminary Efficacy of BNT116 Alone and in Combinations in Patients With Advanced Non-small Cell Lung Cancer
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01852448 · 550 participants
Genetics of Insulin and Incretins in Cystic Fibrosis
- NCT02995252 · 550 participants
The HOPE Study: Characterizing Patients With Hepatitis B and C
- NCT03474913 · 550 participants
Upright MRI for Prostate Cancer Screening
- NCT04761120 · 550 participants
Annuloplasty Rings and Band Post-Market Clinical Follow-Up Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI